scispace - formally typeset
M

Marco Sardiello

Researcher at Baylor College of Medicine

Publications -  61
Citations -  15702

Marco Sardiello is an academic researcher from Baylor College of Medicine. The author has contributed to research in topics: TFEB & Autophagy. The author has an hindex of 32, co-authored 59 publications receiving 12665 citations. Previous affiliations of Marco Sardiello include University of Naples Federico II & Boston Children's Hospital.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

A Gene Network Regulating Lysosomal Biogenesis and Function

TL;DR: It is found that most lysosomal genes exhibit coordinated transcriptional behavior and are regulated by the transcription factor EB (TFEB), providing a potential therapeutic target to enhance cellular clearing in lysOSomal storage disorders and neurodegenerative diseases.
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

Daniel J. Klionsky, +2983 more
- 08 Feb 2021 - 
TL;DR: In this article, the authors present a set of guidelines for investigators to select and interpret methods to examine autophagy and related processes, and for reviewers to provide realistic and reasonable critiques of reports that are focused on these processes.
Journal ArticleDOI

Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways

TL;DR: This analysis revealed a comprehensive system regulating the expression, import and activity of lysosomal enzymes that control the degradation of proteins, glycosaminoglycans, sphingolipids and glycogen, and provides potential therapeutic targets to modulate cellular clearance in a variety of disease conditions.